Semaglutide and stomach emptying in people with diabetes
Part of Brain & nervous system, Hormones & metabolism clinical trials.
This study looks at whether nerve damage from diabetes affects how long semaglutide (a diabetes medicine) stays in the stomach, which can cause stomach retention. It may help doctors understand who is more likely to have this side effect.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have diabetes
- You have been taking semaglutide for at least 4 weeks without stopping
- You are 18 years or older
- You are healthy enough for an endoscopy (a procedure to look inside your stomach)
- You have not had any stomach surgery or a hiatal hernia
- You are not pregnant
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether stopping semaglutide for one week before a sedated endoscopy improves how well the stomach is seen and how quickly it empties. It may help doctors better understand how this medicine affects the procedure.
This study uses an ultrasound to look at how full your stomach is after taking GLP-1 medications for diabetes or weight loss. It will help doctors understand if current fasting guidelines are safe before surgery or a colonoscopy.
This study looks at how quickly food leaves the stomach in healthy people and in those taking semaglutide. It aims to see if semaglutide changes stomach emptying, which could help doctors understand and manage digestive side effects.
This study tests a high dose of semaglutide (a medicine used for weight management) to see how it affects stomach emptying in people with excess weight. Participating may help understand how this treatment works and could lead to better options for weight loss.
This study tests whether a medication called semaglutide (which helps with weight loss) can change the bacteria in your gut, which might play a role in weight regulation. By participating, you may receive a treatment that could help you lose weight while researchers learn more about how it works.
This study looks at how genetics may affect your body’s early response to oral semaglutide, a weight-related diabetes medicine. You may be considered if you are overweight (or overweight with prediabetes) and can safely take part in the research.
Hear when a new Gastric Retention trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.